Resultados de la búsqueda 631-640 of 8099 for Lumbago

  1. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to identify subtype-specific signatures for breast cancer using genomic positioning of plasma DNA fragments, and to validate ...

  2. Oncología (médica) - Ensayos clínicos

    Currently, only a few international institutions use CIRT to treat pelvic bone sarcomas. Accordingly, data evaluating the potential differences in ...

  3. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ...

  4. Ensayos clínicos - Neurología

    The purpose of this study is to evaluate sporadic (s-) and familial (f-) frontotemporal lobar degeneration (FTLD) patients and asymptomatic family members ...

  5. Oncología (médica) - Ensayos clínicos

    Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...

  6. Oncología (médica) - Ensayos clínicos

    The use of this lotion is considered investigational since it hasn't been studied in lymphoma cancer patients with low magnesium levels before; however, the FDA ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to learn about potential side effects facing people who are undergoing treatments for their cancer, specifically, hair loss.

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to examine how well ascorbic acid and combination chemotherapy work in treating patients with lymphoma that has come back or does ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to examine the microbiome and immune function in patients with active lymphoma, and in patients with a history of lymphoma who are ...

  10. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...